Revelation Biosciences Inc (REVB) Financials

$1.01

$0.00 (0.00%)

As on 09-Sep-2026 16:00EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.02	0.03	0.03	0.03	0.04	0.07
Gross Profit	-0.02	-0.03	-0.03	-0.03	-0.04	-0.07
Operating Expenses	11.26	9.07	7.98	8.66	10.86	11.95
Operating Profit (EBIT)	-11.27	-9.07	-7.98	-8.66	-10.86	-11.95
Other Income	--	--	--	--	--	--
Profit before Tax	-10.75	-8.91	-15.04	-0.12	-10.83	-11.99
Provision for Tax	0.00	--	--	0.00	-0.03	-0.22
Profit after Tax (Net Income)	-10.75	-8.91	-15.04	-0.12	-10.83	-11.99
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-2.13

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	10.07	8.86	4.71	6.65	1.05	-0.10
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.55	0.72	--	--	0.55	2.91
Current Liabilities	1.88	2.00	1.91	5.56	4.45	2.14
Total Liabilities	14.38	11.58	6.62	12.21	5.50	2.04

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.81	0.77	0.06	0.07	0.09	0.13
Current Assets	11.68	10.81	6.57	12.15	5.41	1.91
Total Assets	14.38	11.58	6.62	12.21	5.50	2.04
Total Debt*	0.74	0.75	--	--	--	0.02
Net Current Assets	9.80	8.81	4.65	6.58	0.96	-0.23

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-8.27	-18.32	-7.29	-11.22	-11.09
Cash Flow from Investing Activities	--	--	-0.02	--	--	-0.13
Cash from Financing Activities	--	12.47	12.85	14.03	15.20	8.00
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-6.57	-14.36	-43.40	-7.29	-474.98	-32.41
Cash EPS ($)	--	-14.31	-43.32	-5.77	-473.88	-32.37
Adjusted Book Value ($)	--	14.27	13.59	402.89	46.16	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-13.32	-52.88	-441.59	-492.08	-29.99
Free Cash Flow per Share ($)	--	-13.32	-52.93	-441.59	-492.08	-30.35

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-124.53	-264.85	-3.12	-2,233.51	-35.39
ROE (%)	-113.59	-131.38	-264.85	-3.12	-2,272.77	-35.40
ROA (%)	-100.74	-97.93	-159.69	-1.36	-287.04	-31.46
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-34.83	-13.74	7.87	20.32	9.09	-8,113.84
Net Profit Growth (%)	-27.03	40.73	-12,405.64	98.89	9.65	-8,687.49
EPS Growth (%)	72.06	0.67	-4.96	0.98	-13.65	0.88
Book Value Growth (%)	-44.84	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	0.04	-0.06	-0.01	-0.07	0.00	-0.31
Price / Book Value	0.39	0.06	0.03	0.00	0.00	-37.92
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.02	1.05	817.76	1.39	0.48	-0.21
Close Price ($)	1.03	3.20	88.51	2,885.76	38,324.16	2,056,320.00
High Price ($)	12.88	241.92	86,019.84	65,620.80	2,276,064.00	2,163,510.72
Low Price ($)	0.88	3.04	53.95	2,712.96	34,030.08	1,971,648.00
Market Cap ($ Cr)	4.02	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.08	--	--	--	-0.17
Short term debt to equity ratio	0.02	0.00	--	--	2.77	-0.17
Current Ratio	6.21	5.41	3.43	2.18	1.22	0.89
Quick Ratio	6.21	--	--	--	--	--
Interest Coverage	--	--	--	--	-310.75	-286.18

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	9,186.74	14,019.27	13,955.17	5,251.55	3,860.67
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.